Report #2857012

Received Sep 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 30 yrs
State: PA
Recovered: Unknown
Vaccinated: Aug 6, 2025
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
TDAP	TDAP (BOOSTRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	D4J9J	IM

Symptoms (1)

Exposure during pregnancy

Symptom narrative

Drug exposure during pregnancy; This non-serious prospective pregnancy case was reported by a nurse via registry and described the occurrence of vaccine exposure during pregnancy in a 30-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number D4J9J, expiry date 11-JUL-2027) for prophylaxis. On 06-AUG-2025, the patient received the 1st dose of Boostrix (intramuscular). On an unknown date, an unknown time after receiving Boostrix, the patient experienced vaccine exposure during pregnancy (Verbatim: Drug exposure during pregnancy). The outcome of the vaccine exposure during pregnancy was not applicable. Pregnancy exposure: Pregnancy Exposure (Boostrix): Trimester unknown Pregnancy Outcome: Pregnancy was ongoing Additional Information: GSK Receipt Date: 07-AUG-2025 The patient received Boostrix during pregnancy.